Objective: Older patients with bipolar disorder (BD) present with variable degrees of cognitive impairment. Over time, stress, mood episodes, and comorbidities increase the body's allostatic load. We assessed the extent to which allostatic load vs more traditional measures of medical burden account for the heterogeneity in cognition in this population.
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Objective: Older patients with bipolar disorder (BD) present with variable degrees of cognitive impairment. Over time, stress, mood episodes, and comorbidities increase the body's allostatic load. We assessed the extent to which allostatic load vs more traditional measures of medical burden account for the heterogeneity in cognition in this population.
Methods: Thirty-five older euthymic patients with BD and 30 age-equated, gender-equated, and education-equated comparison participants were administered a comprehensive assessment including a neuropsychological battery, and 9 physiological measures to determine allostatic load. The relationship among allostatic load, medical burden, and cognition was assessed.
Results: Compared with the mentally healthy comparators, patients were impaired globally, and in 4 cognitive domains-information-processing speed / executive functioning, delayed memory, language, and visuomotor ability, and presented with greater medical burden but not a different allostatic load. Allostatic load, but not medical burden, was associated with delayed memory performance both in a correlational analysis and in a multivariate regression analysis.
Conclusion: Euthymic older patients with BD are impaired on several cognitive domains and have high medical burden. Their memory performance is more strongly associated with allostatic load than with traditional measures of medical burden. These findings need to be replicated and extended longitudinally. 1 Patients with BD have been reported to have worse cognition, both during acute mood episodes and when in euthymic states. [2] [3] [4] [5] [6] [7] [8] In particular, patients with BD demonstrate impaired information processing speed, executive function, and verbal memory. [9] [10] [11] [12] [13] In turn, these cognitive impairments have been associated with functional impairment. 4, 10, [14] [15] [16] Specifically, decreased information processing speed and impairment in executive functioning are associated with poor Instrumental Activities of Daily Living performance. 3, 17 Co-morbid medical and psychiatric conditions have been associated with cognitive and functional impairment in patients with BD. 9, 18, 19 Specifically, patients with BD have higher levels of obesity, diabetes mellitus, abnormal metabolism, mild renal insufficiency, and high-risk lipoprotein subfractions, 20 as well as other endocrine, metabolic, and respiratory conditions. 18, [21] [22] [23] In addition, increased levels of pro-inflammatory cytokines and glial cell dysfunction have been reported in patients with BD and could increase the risk of cardiovascular disease in this population. 24 How to capture the cumulative impact of these chronic conditions and recurrent mood episodes over the lifetime is a challenge in older patients. Allostatic load has been proposed as such a measure. 21, [25] [26] [27] Allostatic load measures "wear and tear", ie, the cumulative cost of allostasis, the process by which the body responds to stressors to regain homeostasis. 28 Thus, the body's allostatic load due to repeated stress associated with mood episodes and co-morbid conditions has been proposed as an explanation for the cognitive impairment observed in older patients with BD. 25, 27, 29 Seeman et al 30 developed an approach that assesses allostatic load based on 10 indicators: systolic and diastolic blood pressure;
waist-to-hip ratio; total cholesterol-high density lipoprotein (HDL) ratio; total glycosylated hemoglobin; urinary cortisol, norepinephrine, and epinephrine levels; HDL cholesterol level; and serum dihydroepiandrosterone sulfate (DHEA-S) level. The allostatic score is calculated by summing the number of parameters for which the participant falls into the highest quartile except for HDL cholesterol and DHEA-S levels, for which the lowest quartile is used. 30 This allostatic score has been shown to predict cognitive decline in older adults 31 and therefore is a promising predictor of cognitive decline in older patients with BD.
To date, no study assessed allostatic load in patients with BD.
However, it has been hypothesized that BD is a disease of cumulative allostatic load, increasing progressively over time with stressors, mood episodes, and drug abuse. 25, 32 In turn, cognitive impairment in BD could be associated with allostatic load in this population.
Thus, we assessed the degree to which differences in allostatic load account for the heterogeneity of cognitive function in older persons with BD. Based on the literature, we hypothesized that: (1) compared with mentally healthy comparators, patients with BD will exhibit worse allostatic score and poorer cognitive performance, both globally and specifically for the domains of information processing speed, executive function and memory; (2) both burden of physical illness and allostatic load would predict global cognitive performance in older patients with BD, while aging across the geriatric age range will predict information processing speed, executive function and visuomotor ability; and (3) cognitive performance will be more strongly associated with allostatic score than with medical burden. 
| Measures
In addition to the SCID, 17-item Hamilton Depression Rating Scale, Following the approach of Seeman et al, 30 allostatic load was determined based on 9 out of the 10 variables: systolic and diastolic
Key points
• Older patients with bipolar disorder experience cognitive impairment on several domains despite being euthymic.
• They also experience higher medical burden than mentally healthy older adults.
• In these patients, allostatic load, a measure of "wear and tear", but not traditional measures of medical burden, is associated with memory impairment.
blood pressure; waist-to-hip ratio; HDL cholesterol level; total cholesterol-to-HDL cholesterol ratio; DHEA-S; plasma glycosylated hemoglobin; and norepinephrine, and epinephrine. The 10 th variable, 12-hour urinary cortisol, was not available for this study. For each of the 9 variables, participants were placed into quartiles based on the distribution of the scores of the comparator group; they were given a point for each variable that fell into the highest risk quartile, yielding a total possible allostatic score between 0 and 9. The highest risk quartile was the highest quartile for all variables, except for HDL cholesterol and DHEA-S, in which the highest risk quartile was the lowest quartile.
Undetectable epinephrine (<10 pmol/L) were in the lowest quartile and were scored 0. Similarly, when a variable was missing, it was scored 0 (ie, it contributed 0 point towards the allostatic score). time points during the longitudinal study, the time point was also included in step 1 to account for possible practice effects on some cognitive tests.
| Statistical analysis
Then, the allostatic load and the 3 medical burden measures were added Number of prescription drugs 6.6 ± 3.9 1.1 ± 1.7 7.53 (49), P < 0.001
Non-psychotropic 3.7 ± 3.1 1.1 ± 1. one by one for steps 2 to 5 based on the strength of their association with the cognitive scores (ie, the Pearson correlation coefficients). Duration of BD was entered in the sixth and final step.
3 | RESULTS Table 1 summarizes the characteristics of the BD patients and comparators. As expected, patients with BD had higher CIRS-G and FSRP scores and were prescribed significantly more non-psychotropic drugs than the healthy comparators. However, their allostatic measures and load did not differ significantly. Table 2 compares the results of the 20 cognitive tests and presents the 5 cognitive domains z scores.
| Demographic and clinical characteristics
Patients with BD performed significantly more poorly than the comparators on several tests, and they show significantly worse performance for global cognition and for the domains of delayed memory and visuomotor ability but not for the information processing speed/executive function and language domains when correcting for multiple comparisons. Standardized beta coefficients and ΔR 2 values are shown in Table 4 for each step of the hierarchical regression model predicting delayed memory. For language, the model was significant at step 1 only (ΔR 2 = 0.562, F(5,27) = 6.93, P < 0.001 and P = 0.000, Supplemental Table S2 ). For global cognition, the model was significant at step 1 only (ΔR 2 = 0.451, F(5,24) = 3.95, P = 0.009, Supplemental Table S3 ).
| DISCUSSION
Confirming previous studies and congruent with our a priori hypothesis, non-demented euthymic older patients with BD were more impaired in 4 cognitive domains-information-processing speed/ executive functioning, delayed memory, language, and visuomotor ability-and globally than an age-equated comparison group. Even though their premorbid intelligence was the same, patients performed more poorly on 19 of 20 cognitive tests, and the difference in performance was significant for 10 of these tests. As expected, patients with BD presented with a significantly higher burden of co-morbid medical illness (ie, higher CIRS-G score, number of non-psychotropic medications, and FSRP score) than the mentally healthy comparators.
However, contrary to our hypothesis, the allostatic score-a measure TABLE 4 Standardized beta coefficients and ΔR 2 from hierarchical regression to predict delayed memory
Step 1 Step 2 Step 3 Step 4 Step 5
Step 6 of the cumulative cost of allostasis, the process by which the body responds to stressors to regain homeostasis-did not differ between the 2 groups. Still, as predicted, allostatic load was more strongly associated with cognitive performance than the traditional measures of medical burden. Allostatic load was associated with delayed memory performance both in a correlational analysis and in a multivariate regression analysis. Global cognitive performance was associated with age and the FSRP score-an indirect measure of cerebrovascular disease.
Contrary to our expectations, we did not find a difference in allostatic load between older patients with BD and mentally healthy comparators despite the fact that patients with BD had higher measures of medical burden. One possible explanation is that in late life, the wear and tear associated with aging trump the cumulative effects of psychiatric or physical illness. This is consistent with our finding in a larger sample of older patients with BD and comparators showing that oxidative stress measures did not differ between these 2 groups, 40 unlike what has been reported in younger adults. 41 Further,
given that allostatic load is associated with poor health outcomes 42 and death, 43 it is conceivable that the patients with BD who survive into late life despite the burden of BD and physical comorbidities represent a subgroup with an ability to cope with these stressors reflected by a relatively low allostatic load.
Some limitations should be acknowledged. First, we studied a relatively small clinical sample recruited in a psychiatric hospital. Thus, even though our participants were euthymic and relatively stable at the time of testing, our results may not be generalizable to the broader population of older persons with BD. Also, a lack of statistical power may have prevented us from detecting more subtle associations among cognition, medical burden, and allostatic load. However, our sample size was large enough to confirm the differences in cognitive performance and medical burden suggested by prior studies. Also, the very small difference in allostatic score between the patients with BD and the healthy comparators and the small coefficients of correlation between the allostatic score and the information processing speed / executive function domain score suggest that our failure to confirm our related hypotheses is not due to a lack of statistical power. Further, our sample was mostly Caucasian which limits generalizability to other ethnicities. Finally, our analyses cannot control for the heterogeneity of treatment received by our participants with BD. However, their psychopharmacologic regimens were typical, consisting of 2 or 3 psychotropic medications (eg, a combination of a mood stabilizer with an antipsychotic or an antidepressant, possibly supplemented by a medication to promote sleep).
In conclusion, several authors have proposed that allostatic load could be useful in capturing the cumulative impact of chronic conditions in older persons. 25, 26 We believe this is the first study that has used a measure of allostatic load in patients with BD and assessed whether it can predict their cognitive performance. Our results confirm that, relative to mentally healthy comparators, older patients with BD present with both poorer performance in several cognitive domains and an excess burden of physical illness. While their allostatic load is similar to the allostatic load of the comparators, it is more strongly associated with memory performance than traditional measures of medical burden. These findings need to be replicated in a larger study and extended longitudinally.
